Pharma Industry

It wasn’t a one-horse race. We chose Carlyle because of its experience in healthcare: Ajay Piramal


From left, Nandini Piramal, executive director, and Ajay Piramal, chairman, Piramal Enterprises; photo by Bharat Chanda


The Piramal Enterprises chairman recently said global private-equity major Carlyle Group would pick up a 20% stake in its pharmaceutical unit for INR3,700 crore.

Ajay Piramal is an intrepid businessman. He has acquired businesses, grown them, and sold them off at hefty valuations. His decision to diversify into financial services helped transform Piramal Group into a conglomerate. However, the billionaire businessman still holds pharmaceuticals close to his heart. In an exclusive chat with Vikas Dandekar of ET Prime, Ajay Piramal and his daughter Nandini Piramal, executive director of Piramal

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise


Source link